This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Mentor Capital, Inc. (OTCQX:MNTR) announced that it had filed its quarterly 10-Q filing for the second quarter ended June 30, 2018, with the Securities and Exchange Commission.
MNTR GEC GE GNE
The portfolio continues to be heavily concentrated with the top three positions accounting for ~40% of the 13F portfolio.
PCG NSAM.WI CQP PRTK TWX AKBA AR SCACU CAH TRBAB PBF NSAM SLB GE OREX LNG TRBNW VRTV SYF TWC STNL NRF TBPH SCAC SLB MCK OREXQ ATRA SNTL AGN BIIB DIS QRVO GEC NG VSAT ABC CLNY GNE TRCO
After starting off higher on the day, U.S. indices had trouble maintaining altitude throughout the trading session. Worries over Turkey combined with a strong rally over the past six weeks is likely acting as a catalyst for profit taking. Let’s see if there are any opportunities for our top stock trades.
OSTK SQ GE GEC ROKU GNE AMD
U.S. equities are extending to the downside on Monday, with the Dow Jones Industrial Average falling further away from its 20-day moving average to cap a three-day losing streak. Watch for a looming test of the 25,000 level, which has been repeatedly crossed — on the upside and the downside — numerous times since it was first breached back in January.
GE F GEC CAT XOM NEM GS GNE GM MS
August 13, 2018: Here are four stocks trading with heavy volume among 202 equities making new 52-week lows in Monday’s session. On the NYSE decliners led advancers by about 1.93 to 1, and on the Nasdaq, decliners led advancers by about 1.88 to 1.
F GE GEC RAD GNE TIS
A powerful group dedicated to electing Democrats to the House is getting involved for the first time in a safe GOP district in New York after the Republican congressman there was charged with insider trading.
GEC GE GNE
Given Thursday’s lull in the shadow of a clearly overbought condition, it’s not too surprising the bears followed through on Friday. The S&P 500 gave up 0.71% of its value on the last day of the trading week, led lower by General Electric (NYSE:GE) and Ford Motor (NYSE:F). The former fell 1.3% largely in response to news that it may end up selling its power-conversion unit — at a loss — after only buying it in 2011.
OLED GE F GEC DHI PKG GNE CAH
There’s a lot uncertainty in today’s market, but one thing is guaranteed. It’s as sure as the sun rising again tomorrow … The new tax reform law is about to cause an avalanche of money to rush into a very specific kind of investment in the weeks and months ahead — dividends.
WFCNP HD BAC AMZN HON AMAT AAPL CSCO KO MS INTC WFC GE GEC GILD V GNE MSFT
General Electric (GE) is getting dangerously close to closing at new yearly lows. Potential asset sales for the power conversion unit and digital business are doing nothing to get market participants buying the stock again. Needless to say, GE’s run back to $15 in May did not last. What will it take for the stock to stop making fresh 52-week lows?
BHI GEC GE GNE UTX
GlaxoSmithKline’s Hal Barron and former Juno Therapeutics Chief Executive Officer Hans Bishop have another accolade to add to their already impressive resumes – board members. Both men have been appointed to the board of directors of Bay Area-based GRAIL, Inc.
GEC GE A GNE
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...
as of ET